/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Justin
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Justin2023-05-27 08:18:042023-06-27 13:04:56Structure Based Discovery and Anti-fibrotic Activity of Novel Antagonists of Lysophosphatidic Acid Receptor 1 (LPAR1) (Presented at ATS 2023)
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Justin
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Justin2023-05-27 08:17:072023-06-27 13:06:24A First-in-Human Single/Multiple Ascending Dose Study of ANPA-0073, a Novel Small Molecule G-protein Biased Apelin Receptor Agonist, in Healthy Volunteers (Presented at ATS 2023)
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Justin
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Justin2023-05-27 08:16:022023-06-27 13:06:40Discovery of G-protein Biased Small Molecule APJ Agonist for Pulmonary Disease (Presented at ATS 2023)
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2023-01-17 17:29:012023-01-17 17:36:17Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2022-09-06 06:38:572022-12-15 11:00:51Structure Therapeutics CEO Raymond Stevens Named to PharmaVoice 100
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2022-08-01 00:00:052022-08-01 07:08:09Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2022-03-29 11:45:342022-08-01 12:33:25ShouTi Appoints Sharon Tetlow to Board of Directors
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2022-02-17 08:00:432022-08-01 12:33:44ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2022-01-19 08:00:592022-08-23 12:26:19ShouTi Strengthens Board with Appointment of Daniel G. Welch as Chairman
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
0
0
Graham
/wp-content/uploads/StructureTx_LogoUpdate-2022.06.16-Final.svg
Graham2021-10-20 08:00:362022-08-01 12:34:19ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
Scroll to top
